Per-Particle Imaging of Liposomes
Cryo-TEM imaging & automated analysis tools can provide insights into liposomal formulations in their near native state, with just ~50μl of sample.
Validated methods & data inform batch-to-batch, scale-up, and process development change comparisons.
Analyze Multiple Liposome CQA’s in One Dataset
Assess many characteristics of liposomes with one cryo-TEM study:
- Particle morphology
- Lamellarity, including bilayer thickness
- Uniformity
- Particle size distribution
- Estimations of PEG layer thickness
- Cargo encapsulation
- 3D volumes with cryo-electron tomography

Lipid Nanoformulations We Can Image With Cryo or NS TEM

- Lipid Nanoparticles (LNPs), with mRNA, RNA, DNA payloads

Characterize individual liposomes with cryo-TEM imaging
Liposomes are a leading drug delivery vehicle due to their versatility and ability to provide protection to encapsulated drugs, which enhances stability and prevents degradation.
Liposomes consist of one or more lipid bilayers enclosing an aqueous core, and can be used to encapsulate and deliver a wide variety of both hydrophilic and hydrophobic drugs.
Cryo-TEM imaging studies can visualize individual liposome particles, and reveal particle morphology, lamellarity including bilayer thickness, uniformity, particle size distribution, estimations of PEG layer thickness, and cargo encapsulation. These values can be used to inform batch-to-batch, scale-up, and process development change comparisons.
Cryo-TEM can show you if each individual liposome is unilamellar, multilamellar, or multivesicular. Cryo-TEM imaging studies can also assist in determining PEG layer thickness. For a detailed 3D view of each particle, cryo-electron tomography can be performed.

Coming Soon
Learn about Cryo-TEM Studies for Characterizing your Nanoparticles.
Explore Our Services
Explore how our experts can help you.
Frequently Asked Questions
How many particles do you count, or images do you analyze per sample or grid?
How do you measure the PEG layer in liposome formulations?
What type of lipid nanoformulations do you have experience with?
